Abstract
Background and Purpose
Endosaccular flow disruption is a recognized treatment options for treating both unruptured and ruptured aneurysms. The Contour device is designed to target the neck of an aneurysm and cause flow disruption within the aneurysm hence promoting thrombosis and neo-endothelialization at the neck. This article presents initial experiences with the Contour.
Methods
The prospectively maintained database was retrospectively reviewed to identify patients treated with the Contour device. Demographic data, aneurysm characteristics, clinical result, and clinical and radiological follow-up information were recorded.
Results
The review identified 3 patients (2 female), with 3 unruptured aneurysms, of average age 67 ± 8.7 years (range 62–77 years). The aneurysms were all located in the anterior circulation including one pericallosal, one at the A1–2 junction and one on the ICA bifurcation. The mean average dome height was 7.6 ± 0.62 mm (range 7.1–8.3 mm), dome width 5.7 ± 2 mm (range 3.5–7.5 mm), and neck width 3.6 ± 0.95 mm (range 2.5–4.2 mm). At follow-up angiography two of the aneurysms were completely occluded and one device had displaced into the aneurysm sac due to inappropriate positioning of the device. Of the patients one had minor stroke during the postoperative period but returned to baseline neurology. All patients were mRS 0 at last follow-up.
Conclusion
The Contour is a promising new aneurysm occlusion device. Further studies with longer term follow-up are required to determine the efficacy of this novel device.
Similar content being viewed by others
Abbreviations
- AcomA:
-
Anterior communicating artery
- ICA:
-
Internal carotid artery
- MCA:
-
Middle cerebral artery
- mRS:
-
Modified Rankin score
- PCA:
-
Posterior cerebral artery
- PcomA:
-
Posterior communicating artery
- PICA:
-
Posterior inferior cerebellar artery
- RRC:
-
Raymond Roy classification
References
Pierot L, Gubucz I, Buhk JH, Holtmannspötter M, Herbreteau D, Stockx L et al. Safety and efficacy of aneurysm treatment with the WEB: results of the WEBCAST 2 study. AJNR Am J Neuroradiol. 2017;38:1151–5.
Pierot L, Costalat V, Moret J, Szikora I, Klisch J, Herbreteau D et al. Safety and efficacy of aneurysm treatment with WEB: results of the WEBCAST study. J Neurosurg. 2016;124:1250–6.
Pierot L, Spelle L, Molyneux A, Byrne J, WEBCAST and French Observatory Investigators. Clinical and anatomical follow-up in patients with aneurysms treated with the WEB device: 1‑year follow-up report in the cumulated population of 2 prospective, multicenter series (WEBCAST and French observatory). Neurosurgery. 2016;78:133–41.
Fiorella D, Molyneux A, Coon A, Szikora I, Saatci I, Baltacioglu F et al. Demographic, procedural and 30-day safety results from the WEB intra-saccular therapy study (WEB-IT). J Neurointerv Surg. 2017;9:1191–6.
van Rooij SBT, van Rooij WJ, Peluso JP, Sluzewski M, Bechan RS, Kortman HG et al. WEB treatment of ruptured Intracranial aneurysms: a single-center cohort of 100 patients. AJNR Am J Neuroradiol. 2017;38:2282–7.
Lv X, Zhang Y, Jiang W. Systematic review of WEB for wide-necked bifurcation aneurysms: complications adequate occlusion rate, morbidity and mortality. World Neurosurg. 2017;110:20–5.
Raymond J, Guilbert F, Weill A, Georganos SA, Juravsky L, Lambert A et al. Long-term angiographic recurrences after selective endovascular treatment of aneurysms with detachable coils. Stroke. 2003;34:1398–403.
Wiebers DO, Whisnant JP, Huston J 3rd, Meissner I, Brown RD Jr, Piepgras DG et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362:103–10.
Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J et al. International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet. 2002;360:1267–74.
Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA et al. International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366:809–17.
Kadirvel R, Ding YH, Dai D, Rezek I, Lewis DA, Kallmes DF. Cellular mechanisms of aneurysm occlusion after treatment with a flow diverter. Radiology. 2014;270:394–9.
Fahed R, Darsaut TE, Salazkin I, Gevry G, Raymond J. Testing the Medina embolization device in experimental aneurysms. J Neurosurg. 2018; https://doi.org/10.3171/2018.5.JNS18326.
Ding YH, Dai D, Schroeder D, Kadirvel R, Kallmes DF. Experimental testing of the dual-layer woven endobridge device using an elastase-induced aneurysm model in rabbits. Interv Neuroradiol. 2016;22:299–303.
Ding YH, Lewis DA, Kadirvel R, Dai D, Kallmes DF. The woven endobridge: a new aneurysm occlusion device. AJNR Am J Neuroradiol. 2011;32:607–11.
Turk AS, Maia O, Ferreira CC, Freitas D, Mocco J, Hanel R. Periprocedural safety of aneurysm embolization with the Medina coil system: the early human experience. J Neurointerv Surg. 2016;8:168–72.
Aguilar Perez M, Bhogal P, Martinez Moreno R, Bäzner H, Ganslandt O, Henkes H. The Medina embolic device: early clinical experience from a single center. J Neurointerv Surg. 2017;9:77–87.
Bhogal P, Brouwer PA, Yeo L, Svensson M, Söderman M. The Medina embolic device: Karolinska experience. Interv Neuroradiol. 2018;24:4–13.
Sourour NA, Vande Perre S, Maria FD, Papagiannaki C, Gabrieli J, Pistocchi S et al. Medina® embolization device for the treatment of Intracranial aneurysms: safety and angiographic effectiveness at 6 months. Neurosurgery. 2018;82:155–62.
Frölich AM, Nawka MT, Ernst M, Frischmuth I, Fiehler J, Buhk JH. Intra-aneurysmal flow disruption after implantation of the Medina® embolization device depends on aneurysm neck coverage. PLoS ONE. 2018;13:e191975.
Clajus C, Strasilla C, Fiebig T, Sychra V, Fiorella D, Klisch J. Initial and mid-term results from 108 consecutive patients with cerebral aneurysms treated with the WEB device. J Neurointerv Surg. 2017;9:411–7.
Lescher S, du Mesnil de Rochemont R, Berkefeld J. Woven endobridge (WEB) device for endovascular treatment of complex unruptured aneurysms—a single center experience. Neuroradiology. 2016;58:383–90.
Lawson A, Molyneux A, Sellar R, Lamin S, Thomas A, Gholkar A et al. Safety results from the treatment of 109 cerebral aneurysms using the woven endobridge technique: preliminary results in the united kingdom. J Neurosurg. 2018;128:144–53.
Popielski J, Berlis A, Weber W, Fischer S. Two-center experience in the endovascular treatment of ruptured and unruptured intracranial aneurysms using the WEB device: a retrospective analysis. AJNR Am J Neuroradiol. 2018;39:111–7.
Caroff J, Mihalea C, Dargento F, Neki H, Ikka L, Benachour N et al. Woven endobridge (WEB) device for endovascular treatment of ruptured intracranial wide-neck aneurysms: a single-center experience. Neuroradiology. 2014;56:755–61.
Behme D, Berlis A, Weber W. Woven endobridge Intrasaccular flow disrupter for the treatment of ruptured and unruptured wide-neck cerebral aneurysms: report of 55 cases. AJNR Am J Neuroradiol. 2015;36:1501–6.
Herbreteau D, Bibi R, Narata AP, Janot K, Papagiannaki C, Soize S et al. Are anatomic results influenced by WEB shape modification? Analysis in a prospective, single-center series of 39 patients with aneurysms treated with the WEB. AJNR Am J Neuroradiol. 2016;37:2280–6.
Limbucci N, Leone G, Rosi A, Consoli A, Renieri L, Laiso A et al. Endovascular treatment of unruptured Intracranial aneurysms by the woven endobridge device (WEB): are there any aspects influencing aneurysm occlusion? World Neurosurg. 2018;109:e183–93.
Cognard C, Januel AC. Remnants and recurrences after the use of the WEB intrasaccular device in large-neck bifurcation aneurysms. Neurosurgery. 2015;76:522–30. discussion 530.
Funding
This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
P. Bhogal serves as a proctor and consultant for phenox GmbH. P. Lylyk serves as a proctor and consultant for phenox GmbH I. Lylyk, J. Chudyk, N. Perez and C. Bleise declare that they have no competing interests.
Ethical standards
For this article no studies with human participants or animals were performed by any of the authors. All studies performed were in accordance with the ethical standards indicated in each case. Additional written informed consent was obtained from all individual participants or their legal representatives for whom identifying information is included in this article.
Additional information
Author Contributions
PB, JG, CB—data gathering, manuscript preparation,
IL, NP—review, editing
PL—guarantor
Rights and permissions
About this article
Cite this article
Bhogal, P., Lylyk, I., Chudyk, J. et al. The Contour—Early Human Experience of a Novel Aneurysm Occlusion Device. Clin Neuroradiol 31, 147–154 (2021). https://doi.org/10.1007/s00062-020-00876-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00062-020-00876-4